Normal and diffusely abnormal myocardium in humans: Functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging

Radiology

Volumn 179, Issue 1, 1991, Pages 253-259

  Auffermann, Wolfgang ^a,c   Chew, Wilbert M ^a   Wolfe, Christopher L ^a,b   Tavares, Nuno J ^a,d   Parmley, William W ^b   Semelka, Richard C ^a   Donnelly, Tom ^b   Chatterjee, Kanu ^b   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Magnetic resonance (MR), cine study, 511.1214; Magnetic resonance (MR), phosphorus studies, 511.1214, 511.1299; Magnetic resonance (MR), spectroscopy, 511.1214; Myocardium, MR studies, 511.1214; Myocardium, radionuclide studies, 511.1299

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HUMAN; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, CONGESTIVE; FEMALE; HEART; HUMAN; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGE; MOTION PICTURES; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHOSPHOCREATINE; STROKE VOLUME; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026011680     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.179.1.2006287     Document Type: Article

References (27)

1. Higgins CB. MR of the heart: anatomy, physiology, and metabolism. AJR 1988; 151:239-248.
2. Higgins CB, Holt WW, Pflugfelder P, Sechtem U. Functional evaluation of the heart with MRI. Magn Reson Med 1988; 6:121-139.
3. Higgins CB, Byrd BF III, Stark D, et al. Magnetic resonance imaging in hypertrophic cardiomyopathy. Am J Cardiol 1985; 55:1121-1125.
4. Sechtem U, Sommerhoff BA, Markiewicz W, White RD, Cheitlin MD, Higgins CB. Assessment of regional left ventricular wall thickening by magnetic resonance imaging: evaluation in normal persons and patients with global and regional dysfunction. Am J Cardiol 1987; 59:145-151.
5. Whitman GJR, Chance B, Bode H, et al. Diagnosis and therapeutic evaluation of a pediatric case of cardiomyopathy using phosphorus-31 nuclear magnetic resonance spectroscopy. J Am Coll Cardiol 1985; 5:745-749.
6. 31P rotating frame NMR. Proc Natl Acad Sci U S A 1987; 84:4283-4287.
7. 31P magnetic resonance spectroscopy using the rotating frame-depth selection technique. Ann N Y Acad Sci 1987; 508:321-332.
8. Bottomley PA, Herfkens RJ, Smith LS, Bashore TM. Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. Radiology 1987; 165:703-707.
9. Bottomley PA, Charles HC, Roemer PB, et al. Human in vivo phosphate metabolite imaging. Magn Reson Med 1988; 7:310-336.
10. Chew WM, Tavares N, Auffermann W, Higgins CB. An in vivo investigation into the reversibility of obtaining reproducible human myocarctial spectra (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1988; 321.
11. Markiewicz W, Wu S, Parmley WW, et al. Evaluation of the hereditary Syrian hamster cardiomyopathy by P-31 nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy. Circ Res 1986; 59:597-604.
12. Kobayashi A, Yamashita T, Kaneko M, Nishiyama T, Hayashi H, Yamazaki N. Effects of verapamil on experimental cardiomyopathy in the Bio 14.6 Syrian hamster. J Am Coll Cardiol 1987; 10:1128-1134.
13. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987; 508:333-348.
14. Marsh JD, Green LH, Wynne JW, Cohn PF, Grossman W. Left ventricular end-systolic pressure-dimension and stress-length relations in normal human subjects. Am J Cardiol 1979; 44:1311-1317.
15. Stefadouros MA, Dougherty MJ, Grossman W, Craige E. Determination of systemic vascular resistance by a noninvasive technic. Circulation 1973; 47:101-107.
16. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, 1984.
17. Schaefer S, Gober J, Valenza M, et al. Nuclear magnetic resonance imaging guided phosphorus-31 spectroscopy of the human heart. J Am Coll Cardiol 1988; 12:1449-1455.
18. Grist TM, Kneeland JB, Rilling WR, Jesmanowicz A, Froncisz W, Hyde JS. Gated cardiac MR imaging and P-31 MR spectroscopy in humans at 1.5 T. Radiology 1989; 170:357-361.
19. Barany M, Glonek T. Phosphorus-31 nuclear magnetic resonance of contractile systems. Methods Enzymol 1982; 85:624-676.
20. Jasmin G, Proschek L. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle in the UM-X7.1 line. Muscle Nerve 1982; 5:20-25.
21. Chalovich JM, Burt CT, Danon MJ, Glonek T, Barany M. Phosphodiesters and muscular dystrophies. Ann N Y Acad Sci 1979; 317:649-668.
22. Shaw D. In vivo topical magnetic resonance. Organic Magn Reson 1983; 21:225-237.
23. Sarnoff SJ, Braunwald E, Welch GH Jr, Case RB, Stainsby WN, Macruz R. Hemodynamic determinants of oxygen consumption of the heart, with special reference to the tension-time index. Am J Physiol 1958; 192:148-156.
24. Strauer BE. Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy, and coronary reserve. Am J Cardiol 1979; 44:730-740.
25. Gould KL, Libscomb K, Hamilton GW, Kennedy JW. Relation of left ventricular shape, function, and wall stress in man. Am J Cardiol 1974; 34:627-634.
26. Grossman W, Braunwald E, Mann T, McLaurin LP, Green LH. Contractile state of left ventricle in man as evaluated from end-systolic pressure-volume relations. Circulation 1977; 56:845-857.
27. Rudolph W, Schinz A. Studies on myocardial blood flow, oxygen consumption, and myocardial metabolism in patients with cardiomyopathy. Recent Adv Card Struct Metabol 1971; 2:739-749.